Libertarianism, Legitimation, and the Problems of Regulating Cognition-Enhancing Drugs

ISSN： 1874-5490

Source： Neuroethics, Vol.4, Iss.2, 2011-07, pp. : 119-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ispronicline: A novel α4β2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties

By Lippiello Patrick Letchworth Sharon Gatto Gregory Traina Vincent Bencherif Merouane

Journal of Molecular Neuroscience, Vol. 30, Iss. 1-2, 2006-02 ,pp. : 19-20

Humana Press, Inc

Access to resources Recommend Favorite

Cognitive Enhancing Drugs

International Journal of Psychiatry in Clinical Practice, Vol. 8, Iss. 4, 2004-12 ,pp. : 267-267

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Enhancing care for common mental health problems

By Butler Fiona

Primary Care Mental Health, Vol. 3, Iss. 2, 2005-06 ,pp. : 159-162

Radcliffe Press

Access to resources Recommend Favorite

Choline Alphoscerate (Alpha-Glyceryl-Phosphoryl-Choline) An Old Choline- containing Phospholipid with a Still Interesting Profile As Cognition Enhancing Agent

Current Alzheimer Research, Vol. 10, Iss. 10, 2013-12 ,pp. : 1070-1079

Bentham Science Publishers

Access to resources Recommend Favorite

COGNITION on Cognition

By Selnes O.A.

Electroencephalography and Clinical Neurophysiology, Vol. 102, Iss. 6, 1997-06 ,pp. : 519-519

Elsevier

Access to resources Recommend Favorite